Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 10, 2023
Abstract
Background
Microglial
polarization
and
associated
inflammatory
activity
are
key
mediators
of
depression
pathogenesis.
The
natural
Smilax
glabra
rhizomilax
derivative
engeletin
has
been
reported
to
exhibit
robust
anti-inflammatory
activity,
but
no
studies
date
have
examined
the
mechanisms
through
which
it
can
treat
depressive
symptoms.
Purpose
This
study
was
designed
assess
therapeutic
efficacy
in
a
murine
chronic
stress
social
defeat
(CSDS)
model
system
clarify
underlying
mechanisms,
with
particular
focus
on
microglial
polarization.
Methods
CSDS
mice
were
used
test
potential
antidepressant
effects
engeletin.
Following
21-day
treatment
period,
range
assays
including
sucrose
preference
(SPT),
interaction
(SIT),
tail
suspension
(TST),
forced
swim
(FST),
open
field
(OFT)
measure
depressive-like
behaviors
these
mice.
completion
such
behavioral
testing,
3.0
T
multifunctional
magnetic
resonance
imaging
brain
scans
T1-weighted
(T1WI),
T2-weighted
(T2WI),
T2
mapping,
diffusion
tensor
(DTI)
performed.
In
addition,
quantitative
real-time
PCR
(qRT-PCR),
western
blotting
levels
cytokines
interleukin
(IL)-6,
IL-10,
IL-1β,
TNF-α.
Microglia
activation
further
evaluated
immunohistochemical
staining
for
markers
M1
(CD86,
iNOS)
M2
(Arg1,
CD206)
lipocalin-2
(LCN2)/
C-X-C
motif
chemokine
ligand
10
(CXCL10)
signaling
pathway
additionally
assessed
via
whole
transcriptomic
sequencing,
qRT-PCR,
blotting.
Adeno-associated
virus
(AAV)
particles
encoding
LCN2-EGFP
then
infused
into
evaluate
LCN2
overexpression
greater
detail.
Results
Treatment
21
days
significantly
alleviated
T1WI
T2WI
revealed
significant
differences
between
groups,
bilateral
prefrontal
cortex
exhibited
increases
apparent
coefficient
(ADC)
values
relative
normal
control
mice,
corresponding
reduction
fractional
anisotropy
(FA),
while
reversed
all
changes.
resulted
higher
IL-6,
TNF-a
production,
enhanced
activation,
concomitant
decrease
mPFC,
whereas
effectively
abrogated
CSDS-related
pathological
Engeletin
found
suppress
LCN2/CXCL10
axis
that
AAV-induced
ablated
its
beneficial
M1/M2
microglia.
These
data
suggest
correlated
microglia,
highlighting
avenue
future
design
strategies
specifically
target
Conclusion
alleviate
CSDS-induced
by
regulating
thereby
altering
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(4), P. 395 - 395
Published: March 26, 2024
Central
neurological
disorders
are
significant
contributors
to
morbidity,
mortality,
and
long-term
disability
globally
in
modern
society.
These
encompass
neurodegenerative
diseases,
ischemic
brain
traumatic
injury,
epilepsy,
depression,
more.
The
involved
pathogenesis
is
notably
intricate
diverse.
Ferroptosis
neuroinflammation
play
pivotal
roles
elucidating
the
causes
of
cognitive
impairment
stemming
from
these
diseases.
Given
concurrent
occurrence
ferroptosis
due
metabolic
shifts
such
as
iron
ROS,
well
their
critical
central
nervous
disorders,
investigation
into
co-regulatory
mechanism
has
emerged
a
prominent
area
research.
This
paper
delves
mechanisms
along
with
interrelationship.
It
specifically
emphasizes
core
molecules
within
shared
pathways
governing
neuroinflammation,
including
SIRT1,
Nrf2,
NF-κB,
Cox-2,
iNOS/NO·,
how
different
immune
cells
structures
contribute
dysfunction
through
mechanisms.
Researchers’
findings
suggest
that
mutually
promote
each
other
may
represent
key
factors
progression
disorders.
A
deeper
comprehension
common
pathway
between
cellular
holds
promise
for
improving
symptoms
prognosis
related
Journal of Cellular and Molecular Medicine,
Journal Year:
2023,
Volume and Issue:
27(12), P. 1653 - 1663
Published: May 2, 2023
Abstract
High‐mobility
group
box1
(HMGB1)
induces
inflammatory
injury,
and
emerging
reports
suggest
that
it
is
critical
for
brain
ischemia
reperfusion.
Engeletin,
a
natural
Smilax
glabra
rhizomilax
derivative,
reported
to
possess
anti‐inflammatory
activity.
Herein,
we
examined
the
mechanism
of
engeletin‐mediated
neuroprotection
in
rats
having
transient
middle
cerebral
artery
occlusion
(tMCAO)
against
reperfusion
injury.
Male
SD
were
induced
using
1.5
h
tMCAO,
following
by
22.5
h.
Engeletin
(15,
30
or
60
mg/kg)
was
intravenously
administered
immediately
0.5
ischemia.
Based
on
our
results,
engeletin,
dose‐dependent
fashion,
reduced
neurological
deficits,
infarct
size,
histopathological
alterations,
edema
factors,
namely,
circulating
IL‐1β,
TNF‐α,
IL‐6
IFN‐γ.
Furthermore,
engeletin
treatment
markedly
neuronal
apoptosis,
which,
turn,
elevated
Bcl‐2
protein
levels,
while
suppressing
Bax
Cleaved
Caspase‐3
levels.
Meanwhile,
significantly
reduces
overall
expressions
HMGB1,
TLR4,
NF‐κB
attenuated
nuclear
transfer
factor
kappa
B
(NF‐κB)
p65
ischemic
cortical
tissue.
In
conclusion,
strongly
prevents
focal
via
suppression
HMGB1/TLR4/NF‐κB
network.
Journal of Cellular and Molecular Medicine,
Journal Year:
2023,
Volume and Issue:
27(23), P. 3928 - 3938
Published: Oct. 6, 2023
Abstract
Major
depressive
disorder
(MDD)
is
a
severe
mental
associated
with
high
rates
of
morbidity
and
mortality.
Current
first‐line
pharmacotherapies
for
MDD
are
based
on
enhancement
monoaminergic
neurotransmission,
but
these
antidepressants
still
insufficient
produce
significant
side‐effects.
Consequently,
the
development
novel
therapeutic
targets
desired.
Engeletin,
natural
Smilax
glabra
rhizomilax
derivative,
compound
proven
efficacy
in
treating
ischemic
stroke,
yet
its
effects
mechanisms
depression
remain
unexplored.
The
engeletin
were
assessed
forced
swimming
test
(FST)
tail
suspension
(TST)
mice.
Engeletin
was
also
investigated
chronic
restraint
stress
(CRS)
mouse
model
fluoxetine
(FLX)
as
positive
control.
Changes
prefrontal
cortex
(PFC)
spine
density,
synaptic
plasticity‐linked
protein
expressions
brain‐derived
neurotrophic
factor
(BDNF)‐tyrosine
kinase
B
(TrkB)‐
mammalian
target
rapamycin
complex
1
(mTORC1)
signalling
pathway
after
treatment
then
investigated.
TrkB
mTORC1
selective
inhibitors,
ANA‐12
rapamycin,
respectively,
utilized
to
assess
engeletin's
antidepressive
mechanisms.
Our
data
shows
that
exhibited
antidepressant‐like
activity
FST
TST
mice
without
affecting
locomotor
activity.
Furthermore,
it
efficiency
against
CRS
model.
Moreover,
enhanced
BDNF‐TrkB‐mTORC1
PFC
during
altered
reduction
dendritic
density
levels
induced
by
CRS.
In
conclusion,
has
antidepressant
via
activation
upregulation
plasticity.
Journal of Ethnopharmacology,
Journal Year:
2024,
Volume and Issue:
336, P. 118733 - 118733
Published: Aug. 23, 2024
Smilax
glabra
rhizome
has
a
long
history
been
used
for
clinical
purposes
in
traditional
Chinese
medicinal
treating
various
inflammatory
conditions.
Engeletin
International Journal of Developmental Neuroscience,
Journal Year:
2023,
Volume and Issue:
84(2), P. 87 - 98
Published: Dec. 18, 2023
Abstract
Autism
spectrum
disorder
(ASD)
is
the
fastest‐growing
neurodevelopmental
disease
throughout
world.
Neuro‐immune
responses
from
prenatal
to
adulthood
stages
of
life
induce
developmental
defects
in
synaptic
signaling,
neurotransmitter
imbalance,
and
even
structural
changes
brain.
In
this
study,
we
aimed
focus
on
possible
role
neuroinflammatory
response
hippocampus
development
autistic‐like
behaviors
following
maternal
separation
(MS)
stress
mice.
To
do
this,
mice
neonates
daily
separated
their
mothers
postnatal
day
(PND)
2
PND
14
for
3
h.
During
PND45–60,
behavioral
tests
related
including
three‐chamber
sociability,
Morris
water
maze
(MWM),
shuttle
box,
resident‐intruder,
marble
burying
were
performed.
Then,
hippocampi
dissected
out,
gene
expression
inflammatory
mediators
TNF‐α,
IL‐1β,
TLR4,
HMGB1,
NLRP3
was
assessed
using
RT‐PCR.
Results
showed
that
MS
exerted
impaired
sociability
preference,
repetitive
behaviors,
passive
avoidance,
spatial
memories.
The
significantly
increased
We
concluded
probably
via
activating
HMGB1/TLR4
signaling
cascade
induced
Journal of Cellular and Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
28(8)
Published: April 1, 2024
Microglial
polarization
and
associated
inflammatory
activity
are
the
key
mediators
of
depression
pathogenesis.
The
natural
Smilax
glabra
rhizomilax
derivative
engeletin
has
been
reported
to
exhibit
robust
anti-inflammatory
activity,
but
no
studies
date
have
examined
mechanisms
through
which
it
can
treat
depressive
symptoms.
We
showed
that
treatment
for
21
days
with
significantly
alleviated
depressive-like
behaviours
in
chronic
stress
social
defeat
(CSDS)
model
mice.
T1-weighted
imaging
(T1WI),
T2-weighted
(T2WI)
revealed
significant
differences
between
groups,
bilateral
prefrontal
cortex
CSDS
mice
exhibited
increases
apparent
diffusion
coefficient
T2
values
relative
normal
control
mice,
a
corresponding
reduction
fractional
anisotropy,
while
reversed
all
these
changes.
resulted
higher
levels
IL-1β,
IL-6,
TNF-a
production,
enhanced
microglial
activation,
greater
M1
concomitant
decrease
M2
mPFC,
whereas
effectively
abrogated
CSDS-related
pathological
Engeletin
was
further
found
suppress
LCN2/C-X-C
motif
chemokine
ligand
10
(CXCL10)
signalling
axis
such
adeno-associated
virus-induced
LCN2
overexpression
ablated
antidepressant
effects
its
beneficial
on
M1/M2
microglia.
In
conclusion,
alleviate
CSDS-induced
by
regulating
LCN2/CXCL10
pathway
thereby
altering
These
data
suggest
correlated
microglia,
highlighting
potential
avenue
future
design
strategies
specifically
target
eNeuro,
Journal Year:
2025,
Volume and Issue:
unknown, P. ENEURO.0347 - 24.2024
Published: Jan. 9, 2025
Acute
ischemic
stroke
(AIS)
is
a
dangerous
neurological
disease
associated
with
an
imbalance
in
Th17/Treg
cells
and
abnormal
activation
of
the
Wnt/β-catenin
signaling
pathway.
This
study
aims
to
investigate
whether
inhibition
miR-155
can
activate
pathway
improve
provide
neuroprotective
effects
against
stroke.
We
employed
multi-level
experimental
design.
Firstly,
we
analyzed
differential
gene
expression
between
antagomir-treated
group
control
using
high-throughput
sequencing
identify
potential
target
genes.
Subsequently,
conducted
functional
enrichment
analysis
differentially
expressed
genes
bioinformatics
tools.
Next,
performed
vivo
animal
experiments
mouse
model
validate
impact
antagomir
treatment
on
improvement
cell
ratios.
Lastly,
vitro
our
findings
further.
High-throughput
results
showed
significant
(BioProject:
PRJNA1152758,
SRA
IDs:
SRR30410532,
SRR30410531,
SRR30410530
for
group;
SRR30410529,
SRR30410528,
SRR30410527
group).
Bioinformatics
revealed
imbalance.
In
demonstrated
that
significantly
activated
improved
vivo,
experiment
indicated
exhibited
AIS.
demonstrates
by
activating
exhibiting
AIS
model.
These
crucial
support
as
therapeutic
strategy
lay
foundation
further
research.
Significance
Statement
identifies
pivotal
regulator
balance
By
inhibiting
miR-155,
demonstrate
enhance
neuroprotection
modulate
immune
responses,
offering
promising
avenue
management.
contribute
growing
understanding
molecular
mechanisms
developing
miR-155-targeted
therapies.